A detailed history of Australian Super Pty LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Australian Super Pty LTD holds 7,893,376 shares of TEVA stock, worth $138 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
7,893,376
Previous 8,505,102 7.19%
Holding current value
$138 Million
Previous $138 Million 2.92%
% of portfolio
0.73%
Previous 0.81%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$15.81 - $18.96 $9.67 Million - $11.6 Million
-611,726 Reduced 7.19%
7,893,376 $142 Million
Q2 2024

Jul 26, 2024

SELL
$12.78 - $17.4 $20.5 Million - $28 Million
-1,606,968 Reduced 15.89%
8,505,102 $138 Million
Q1 2024

Apr 26, 2024

BUY
$10.67 - $14.43 $11.4 Million - $15.5 Million
1,073,000 Added 11.87%
10,112,070 $143 Million
Q4 2023

Jan 16, 2024

BUY
$8.12 - $10.63 $11.6 Million - $15.2 Million
1,431,671 Added 18.82%
9,039,070 $94.4 Million
Q3 2023

Oct 27, 2023

BUY
$7.48 - $10.7 $4.97 Million - $7.11 Million
664,152 Added 9.57%
7,607,399 $77.6 Million
Q2 2023

Jul 28, 2023

BUY
$7.2 - $9.47 $32.6 Million - $42.8 Million
4,523,700 Added 186.96%
6,943,247 $52.3 Million
Q4 2022

Feb 01, 2023

SELL
$7.95 - $9.48 $3.48 Million - $4.15 Million
-437,442 Reduced 15.31%
2,419,547 $22.1 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $6.14 Million - $10.7 Million
895,242 Added 45.63%
2,856,989 $23.1 Million
Q2 2022

Jul 13, 2022

SELL
$7.38 - $10.4 $5.19 Million - $7.31 Million
-702,819 Reduced 26.38%
1,961,747 $14.8 Million
Q1 2022

Apr 29, 2022

BUY
$7.33 - $9.39 $2.61 Million - $3.34 Million
355,662 Added 15.4%
2,664,566 $25 Million
Q4 2021

Jan 24, 2022

SELL
$7.9 - $10.19 $1 Million - $1.29 Million
-126,851 Reduced 5.21%
2,308,904 $19.4 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $3.55 Million - $4.32 Million
-424,038 Reduced 14.83%
2,435,755 $23.7 Million
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $8.78 Million - $10.3 Million
887,092 Added 44.97%
2,859,793 $28.3 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $15.8 Million - $19.5 Million
1,524,197 Added 339.84%
1,972,701 $22.8 Million
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $1.96 Million - $2.51 Million
227,592 Added 103.02%
448,504 $4.33 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $1.89 Million - $2.8 Million
220,912 New
220,912 $1.99 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.